Max Uniorange Pharma (India) Private Limited - Company Profile

It is a trading private limited company based in Cochin, Kerala, India, established in 2009.
2009 Cochin, Kerala, India Under Process Of Striking Off
Last Updated:
Access Report
About Max Uniorange Pharma (India) Private Limited

Max Uniorange Pharma (India) Private Limited, a under process of striking off private limited company, was established on 26 June 2009 in Cochin, Kerala, India. Engaging in other wholesale within the trade sector, it holds CIN: U24233KL2009PTC024373. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Its leadership includes Thomas Varkey Padingare Chempanal (Whole-Time Director), Abdulrahim Aboobacker Pallimuttathe (Whole-Time Director), Vijayan Praveen (Whole-Time Director). Past directors included Raghunandan Govinda Menon, Putharadathu Narayanan Bhavanendranathan Nair, Rajeswar Dayal Chandrasekharan Nair. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 3/335 - K, 2Nd Floor, Jogeo Building P. T. Road, Kakkanad, Cochin, Kerala, 682021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233KL2009PTC024373

  • Registration Number

    024373

  • Incorporation Date

    26 June 2009

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Ernakulam

  • Listing Status

    Unlisted

  • Company Status

    Under Process Of Striking Off

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 16 Year, 8 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Max Uniorange Pharma (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Max Uniorange Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Max Uniorange Pharma (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Thomas Varkey Padingare Chempanal Whole-Time Director 26 Jun 2009 Current
Abdulrahim Aboobacker Pallimuttathe Whole-Time Director 26 Jun 2009 Current
Vijayan Praveen Whole-Time Director 26 Jun 2009 Current
John Thottumkal Thomas Whole-Time Director 26 Jun 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Apr 2019 Past
Pramod Abcsdd Whole-Time Director 12 Apr 2019 Past
Pramod Abcsdd Whole-Time Director 12 Apr 2019 Past
Pramod Abcsdd Director 25 Feb 2011 Past
Pramod Abcsdd Director 25 Feb 2011 Past
Pramod Abcsdd Director 25 Feb 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Max Uniorange Pharma (India).

Max Uniorange Pharma (India) Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Max Uniorange Pharma (India) revenue growth over time
Max Uniorange Pharma (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Max Uniorange Pharma (India)?

In 2017, Max Uniorange Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Max Uniorange Pharma (India)?

Unlock and access historical data on people associated with Max Uniorange Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Max Uniorange Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Max Uniorange Pharma (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Max Uniorange Pharma (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Max Uniorange Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Max Uniorange Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam. was completed.

  • Director Appointment

    Progress on Thomas Varkey Padingare Chempanal was appointed as a Whole-time director was appointed as a Whole-time director on 26 Jun 2009 & has been associated with this company since 16 years 8 months . was documented.

  • Director Appointment

    The activity Abdulrahim Aboobacker Pallimuttathe was appointed as a Whole-time director was appointed as a Whole-time director on 26 Jun 2009 & has been associated with this company since 16 years 8 months . was completed.

  • Director Appointment

    Progress on Vijayan Praveen was appointed as a Whole-time director was appointed as a Whole-time director on 26 Jun 2009 & has been associated with this company since 16 years 8 months . was documented.

  • Director Appointment

    Progress on John Thottumkal Thomas was appointed as a Whole-time director was appointed as a Whole-time director on 26 Jun 2009 & has been associated with this company since 16 years 8 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Max Uniorange Pharma (India) Private Limited?

The CIN of Max Uniorange Pharma (India) Private Limited is U24233KL2009PTC024373.

Where is Max Uniorange Pharma (India) Private Limited headquartered?

Max Uniorange Pharma (India) Private Limited is headquartered at 3/335 - K, 2Nd Floor, Jogeo Building P. T. Road, Kakkanad, Cochin, Kerala, 682021.

When was Max Uniorange Pharma (India) Private Limited incorporated?

Max Uniorange Pharma (India) Private Limited was incorporated on 26 June 2009.

Who are the current directors of Max Uniorange Pharma (India) Private Limited?

The current directors of Max Uniorange Pharma (India) Private Limited are

What is the primary industry of Max Uniorange Pharma (India) Private Limited?

The primary industry of Max Uniorange Pharma (India) Private Limited is Trade.

Is Max Uniorange Pharma (India) Private Limited a listed company?

Max Uniorange Pharma (India) Private Limited is unlisted.

What is the capital structure of Max Uniorange Pharma (India) Private Limited?

The authorized capital of Max Uniorange Pharma (India) Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Max Uniorange Pharma (India) Private Limited?

The compliance status of Max Uniorange Pharma (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available